Audit 331419

FY End
2024-03-31
Total Expended
$1.01M
Findings
0
Programs
2
Year: 2024 Accepted: 2024-12-09
Auditor: Marcum LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.855 Allergy and Infectious Diseases Research $766,551 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $240,416 Yes 0

Contacts

Name Title Type
XLCWGCZH8NJ4 Chris Bluhm Auditee
3012721184 Douglas Boedeker Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: American Gastroenterological Association, Inc. and Affiliates elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards of the American Gastroenterological Association, Inc. and Affiliates is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.